By Tim O’Neill
In 2006, my then 33-years-young wife, Kirsten, was diagnosed with Stage III rectal cancer. Her diagnosis was completely unexpected; she was young, a non-smoker and in overall good health. She had chemotherapy and multiple surgeries. Thankfully, we navigated the treatment with an excellent team of healthcare providers, loving family and caring friends.
About three months into her treatment I decided to address a nagging swollen lymph node under my jaw. Fully expecting a Lyme disease diagnosis, I was dismissive. But considering what my wife was going through, I thought I’d better be safe than sorry.
Reports of an experimental drug that slowed advanced breast cancer in a clinical trial have stirred excitement at a national research meeting and breathed new life into a cancer-fighting strategy that had seemed to falter.
When 15-year-old Karina Moreira sat down with Brazilian model Gisele Bundchen in December 2013, the two traded beauty tips, talked fashion, and took turns applying makeup. They spoke in their native Portuguese and laughed with family and friends. The experience, Moreira says, one that she will remember for the rest of her life.
But the two talked about more than just eye shadow and clothes; they also talked about life and Moreira’s battle with bone cancer. Bundchen, who surprised Moreira at home, offered some advice for the young girl: “When life gives you lemons, make lemonade.”
For more than five years, Sally Boyd had repeated needle punctures in her arm for blood draws, chemotherapy, and other procedures for multiple myeloma.
“The nurses said I had good veins, so at first it was easy for them to insert the needle,” Boyd recalls. “But as time went on, my arms were bruised and sore.”
It’s been suggested that regular use of talcum powder products in the genital area might increase the possibility of ovarian cancer. In theory, particles of talc could travel through the reproductive tract to the ovaries and cause cancer. Research on this potential link has yielded mixed findings, with some studies finding a small increase in risk.
One of the most difficult aspects of having cancer is deciding who to tell and when. For young adults who may be attending college, maintaining an active social life, or starting a family, these questions are especially critical.
Karen Fasciano, PsyD, and her colleagues in the Young Adult Program at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), addressed these questions and others at the 11th annual Young Adult Cancer Conference last month. Bruce MacDonald, MSW, LICSW, who leads the young adult cancer support group at DF/BWCC, spoke with patients about sharing their diagnoses with three critical groups:
Although it is not a common disease, esophageal cancer affects about 18,000 new patients each year in the United States. Typically, the disease is found more often in men than in women, with men having about a ten-fold higher risk of developing esophageal cancer.
“Esophageal and gastric cancers are some of the most stubborn and aggressive cancers that we treat in the United States today,” explains Peter Enzinger, MD, director of the Center for Esophageal and Gastric Cancer at Dana-Farber. “Therapies must be quite aggressive to treat these cancers, but we must know how to effectively treat any side effects as well.”
Cancer patients are at a higher risk than the general population of developing serious blood clots, including deep vein thrombosis (DVT) in the legs or pulmonary emboli in the lungs, which can be fatal.
A young woman in her prime, with a full life and meaningful career, does not expect a cancer diagnosis. But that is what happened to 34-year-old Erin, who received the news when she was in Paris with her mother and sister, on a long-awaited trip to celebrate Mother’s Day. Read more